YI — Stock Film
STOCK FILMSCENE 1/11YI · $3.59
Stock Expert AI presents
YI
111, Inc
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
111, Inc. What it actually does.

Operates an integrated online and offline healthcare platform in China. Sells medical and wellness products through online retail and wholesale channels. Now — the numbers.

on the stock market since 2018
1,063 employees
$31.4M market value
WHERE DOES THE MONEY COME FROM?
50%Products
ProductsDrugs 46%Nutritional Supplements 2%Other Products 1%Medical Supplies and Devices 1%Other 1%
50% of all revenue comes from a single line: Products.

The biggest line carries real weight, but it doesn’t decide everything on its own.

Revenue last year:
$1.8B
The loss that same year:
$2.5M
Sales don’t cover the costs; the gap drains from the cash pile every year.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

THE SALES TREND
Sales are moving sideways.

No real growth. Red columns mark years that ended in a loss.

$1.9B
2021
2022
2023
2024
$1.8B
2025
In the vault right now:
$91.3M
DEBT: $32.5M
At this pace, that money lasts about 36.3 years.

At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
63
average

Profit indicators sit around the sector average.

FINANCIAL STRENGTH
65
strong

The cash pile is strong; debt and other items pull the grade toward the middle.

VALUATION
58
average

The price isn’t cheap next to earnings — that’s why this grade sits in the middle.

GROWTH
38
weak

Clearly below the class average.

PRICE MOMENTUM
22
very weak

Clearly below the class average.

WORTH WATCHING

Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.

Growth: Sales growth trails the sector average.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 94% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/1
Strong cash, light debt

There is $91.3M in the vault; even if every debt were paid off, $58.8M would remain.

1
THE RISKS · 1/3
The losses continue

A loss of $2.5M against $1.8B in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/3
The stock has lost its spark

Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 22/100. For a turnaround signal, the stock first needs to close the gap with the market.

3
THE RISKS · 3/3
Growth trails the sector

The growth engine is running at low revs right now. Report-card grade: 38/100.

FINALE · THE GRADE
D
39 / 100 · MoonshotScore

On our five-subject report card, YI sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: YI’s sales are going backwards, and it closed last year at a loss. The road back runs through both.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: earnings execution.

This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film